PolyU IR
 

PolyU Institutional Repository >
Health Technology and Informatics >
HTI Journal/Magazine Articles >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/1789

Title: Ganoderma lucidum (‘Lingzhi’), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study
Authors: Wachtel-Galor, Sissi
Tomlinson, Brian
Benzie, Iris F. F.
Subjects: Lingzhi
Ganoderma lucidum
Supplementation studies
Herbal medicine
Issue Date: Feb-2004
Publisher: Cambridge University Press on behalf of The Nutrition Society
Citation: British Journal of Nutrition, Feb. 2004, v. 91, no. 2, p. 263-269.
Abstract: Lingzhi (Ganoderma lucidum) is a woody mushroom highly regarded in traditional medicine and is widely consumed in the belief that it promotes health and longevity, lowers the risk of cancer and heart disease and boosts the immune system. However, objective scientific validation of the putative health benefits of Lingzhi in human subjects is lacking, and issues of possible toxicity must be addressed. The present double-blinded, placebo-controlled, cross-over intervention study investigated the effects of 4 weeks Lingzhi supplementation on a range of biomarkers for antioxidant status, CHD risk, DNA damage, immune status, and inflammation, as well as markers of liver and renal toxicity. It was performed as a follow-up to a study that showed that antioxidant power in plasma increased after Lingzhi ingestion, and that 10 d supplementation was associated with a trend towards an improved CHD biomarker profile. In the present study, fasting blood and urine from healthy, consenting adults (n 18; aged 22–52 years) was collected before and after 4 weeks supplementation with a commercially available encapsulated Lingzhi preparation (1·44 g Lingzhi/d; equivalent to 13·2 g fresh mushroom/d) or placebo. No significant change in any of the variables was found, although a slight trend toward lower lipids was again seen, and antioxidant capacity in urine increased. The results showed no evidence of liver, renal or DNA toxicity with Lingzhi intake, and this is reassuring. The present study of the effects in healthy, well-nourished subjects provides useful, new scientific data that will support controlled intervention trials using at-risk subjects in order to assess the therapeutic effect of Lingzhi in the promotion of healthy ageing.
Description: DOI: 10.1079/BJN20041039
Rights: © The Authors 2004.
The journal web page is located at: http://journals.cambridge.org/action/displayJournal?jid=BJN
Type: Journal/Magazine Article
URI: http://hdl.handle.net/10397/1789
ISSN: 0007-1145
1475-2662 (EISSN)
Appears in Collections:HTI Journal/Magazine Articles

Files in This Item:

File Description SizeFormat
Ganoderma lucidum ('Lingzhi')_biomarker responses in a controlled human supplementation study.pdf130.85 kBAdobe PDFView/Open



Facebook Facebook del.icio.us del.icio.us LinkedIn LinkedIn


All items in the PolyU Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
No item in the PolyU IR may be reproduced for commercial or resale purposes.

 

© Pao Yue-kong Library, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong
Powered by DSpace (Version 1.5.2)  © MIT and HP
Feedback | Privacy Policy Statement | Copyright & Restrictions - Feedback